
Please try another search
Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics, such as in automated immunoassays used in blood testing. The Company offers a portfolio of antibodies to customers for both commercial use and research and development (R&D) purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The Company supplies its antibody products and services to multinational clinical diagnostics companies. It has developed a sheep hybridoma technology to produce productive cell lines that secrete sheep monoclonal antibodies (SMAs) of high affinity. The Company sells its products through direct sales and through distributors.
Name | Age | Since | Title |
---|---|---|---|
Ian James Nicholson | 62 | 2004 | Independent Non-Executive Chairman |
Nicholas John McCooke | 69 | 2014 | Independent Non-Executive Director |
Peter John Harrison | 64 | - | CEO & Director |
Bruce Edward Heath Hiscock | 64 | 2020 | CFO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review